Anna L. Southam

The prognosis for adolescents with menstrual abnormalities

Abstract Dysfunctional uterine bleeding . Fifty per cent of adolescents with dysfunctional uterine bleeding will have no more than 4 years of continued abnormality. However, after 4 abnormal years the chance of recovery is low. Gynecologic morbidity measured in terms of transfusions and operative procedures is high. Twenty-four per cent of the total group were treated surgically. Four cases of endometrial cancer occurred between the ages of 23 and 33. Reproductive potential is decreased even though the menstrual pattern becomes normal. Oligomenorrhea . Fifty per cent of adolescents with oligomenorrhea establish regular menstrual cycles in less than 2 years. Few require hospital admission. Laparotomies were done on 8.5 per cent of the total group. Only 1 malignant tumor, an ovarian carcinoma, was found among 247 patients. Fertility may be slightly impaired in women who continue to have this symptom.

Systemic changes during the menstrual cycle.

The article reviews the systemic changes which have been observed during the menstrual cycle. The findings of studies from the medical literature of the nineteenth and twentieth centuries of physiological changes in the vital signs pulse and blood pressure respiration weight hematological functions vitamins endocrine functions breasts mucus cytological conditions skeletal form skin conditions gastrointestinal tract autonomic nervous system central nervous system mental and physical efficiency behavior and emotions premenstrual tension and systemic disease are reported and contrasted. It is concluded that further documentation and reevaluation of some of the studies presented by modern techniques is needed.

Immunofluorescent study of the ABO blood group antigens in human spermatozoa.

Abstract 1. 1. The presence of blood group antigens A or B on human spermatozoa has been demonstrated with the use of specific immunofluorescent antisera. 2. 2. The evidence indicates that the spermatozoa carry a single ABO blood group antigen on their surface in contrast to the somatic cells.